ClinConnect ClinConnect Logo
Search / Trial NCT06099522

Internet-CBT for Gambling Disorder - a Randomized Controlled Trial

Launched by KAROLINSKA INSTITUTET · Oct 24, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the effectiveness of internet-based cognitive behavioral therapy (iCBT) for people with gambling disorder. The study will enroll 150 participants, who will be randomly assigned to either receive the iCBT treatment along with a support tool called "Spelpaus," or to use "Spelpaus" alone without the therapy. Throughout the study, researchers will track participants' progress at different times, including before treatment, weekly during treatment, and after treatment at three and six months.

To be eligible for the trial, participants must be at least 18 years old and show signs of gambling disorder based on a specific screening test. They should also be able to use "Spelpaus," which is a tool that helps individuals take a break from gambling. However, those who are currently receiving other treatments for gambling disorder or who have severe depression or thoughts of self-harm are not eligible to participate. This study is currently recruiting participants, and it aims to provide valuable insights into how effective online therapy can be for treating gambling issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Screen positive for GD, as measured with the Gambling Disorder Identification Test (total score ≥20 GDIT).
  • Fulfilling GD, assessed according to the Structured Clinical Interview for Gambling Disorder (SCI-GD).
  • Utilization of "Spelpaus", 3 months from treatment start.
  • ≥18 years of age.
  • Able to provide digital informed consent.
  • Exclusion Criteria:
  • Other ongoing psychological treatment for GD.
  • Severe depression, screened according to the Montgomery Åsberg Depression Rating Scale (total score \>34 MADRS-S).
  • Suicidality, screening of ≥4 points on item 9 of the MADRS-S

About Karolinska Institutet

Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.

Locations

Stockholm, , Sweden

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported